Ningbo Medsun Medical Co., Ltd.

Ningbo Medsun Medical Co., Ltd. — FDA 510(k) Submissions

Ningbo Medsun Medical Co., Ltd. has submitted 6 FDA 510(k) premarket notifications since 2022, of which 6 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature, Needle, Hypodermic, Single Lumen, Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature . Use the specialty filter in the sidebar to narrow results.